INTRODUCTION
Caspases are a class of cysteine proteases that play a critical role during apoptosis [1, 2] . They are normally present as proenzymes in the cytoplasm. Upon activation, the caspases cleave a variety of cellular substrates after aspartate residues, thereby initiating the orderly dismantling of the cell. Activation involves proteolytic conversion of a procaspase zymogen to the active form. This occurs rapidly after triggering of apoptosis, and is seen with a wide variety of apoptotic stimuli. Little is known about the earliest steps involved in procaspase activation. The best-characterized system is ligation of the Fas (CD95\APO-1) receptor, where protein-protein interactions via ' death domains ' initiate the recruitment and activation of procaspases-8 and -10, which are able to cleave, and thereby activate, other members of the caspase family [3] . In the majority of other systems, however, the pathway to caspase activation is unclear.
It has recently been reported that addition of dATP and cytochrome c to cytosolic extracts is sufficient to initiate caspase activation [4] . Subsequently, it has been shown that cytochrome c is released from mitochondria into the cytoplasm of apoptotic cells, and that this may occur at a sufficiently early stage to be an important trigger of the apoptotic programme [4] [5] [6] . However, the mechanism of this proposed cytochrome c release is currently unclear. Mitochondria have received considerable attention in recent times with regard to their involvement in apoptosis [7] . Interest has centred around the opening of mitochondrial transition pores and the release of various proapoptotic factors. Cytochrome c may be released this way ; however, a more specific transport of cytochrome c could also occur. Regardless of the mechanism, the anti-apoptotic protein Bcl-2 can block cytochrome c release, providing further support for the importance of this mechanism in apoptosis [5, 6] .
We have utilized the in itro model with cytoplasmic extracts to investigate the mechanism by which cytochrome c activates Abbreviations used : AMC, aminomethylcoumarin ; DEVD, acetyl-Asp-Glu-Val-Pro tetrapeptide ; DEVD-AMC, acetyl-L-aspartyl-L-glutamyl-L-valyl-Laspartic acid α-(4-methylcoumaryl-7-amide) ; DTT, dithiothreitol. 1 To whom correspondence should be addressed.
stringent allosteric interactions between cytochrome c and other cytoplasmic factors are necessary. Cytochrome c was fully reduced within 5 min of addition to the cytosolic extracts. Potassium ferricyanide could maintain cytochrome c in an oxidized state, but care was taken to use ferricyanide at concentrations where its polyanion effect did not cause interference. The oxidized form of cytochrome c was able to activate the caspases. We conclude that reduced cytochrome c will function in the cytoplasm ; however, its reduction is not a critical step, and electron transfer from cytochrome c to its cytoplasmic-binding partner(s) is not necessary in the pathway leading to apoptosis.
the caspases. In its traditional role in the respiratory chain, cytochrome c shuttles electrons between complexes III and IV on the inner mitochondrial membrane. It has a haem group to carry electrons, and a highly conserved tertiary structure which mediates electrostatic interactions with the target complexes and the membrane [8] . Here we investigated the importance of these features, with a particular interest in determining if the redox state of cytochrome c is an important component in the pathway leading to caspase activation. Related haem compounds or modified cytochrome c were ineffective triggers, and increasing the ionic strength of the cytosol impaired the ability of cytochrome c to activate the caspases, indicating that critical proteinprotein interactions were involved. We also showed that cytochrome c in the cytosol functioned while in its reduced state. However, the oxidized form could also function effectively, indicating that redox reactions of cytochrome c were not necessary for caspase activation. This work was presented in part at the Keystone Symposia on Apoptosis and Programmed Cell Death in Tamarron, CO, U.S.A., February 18-23, 1997.
EXPERIMENTAL Materials
Jurkat T-lymphocytes were obtained from the European Type Culture Collection. Rabbit anti-p17 antibodies of caspase-3 were kindly donated by Dr. Donald W. Nicholson (Merck Frosst Center for Therapeutic Research, Pointe-Claire-Dorval, Quebec, Canada). Rabbit anti-(caspase-7) antibodies were raised in our laboratory against the peptide CKPDRRSSFVPSLFSKK from the p20 subunit of caspase-7 [9] . Goat anti-(rabbit IgG)-horseradish peroxidase was from Pierce (Rockford, IL, U.S.A.). Enhanced chemiluminescence system was from Amersham Corp. (Buckinghamshire, U.K.). Acetyl--aspartyl--glutamyl--valyl--aspartic acid α-(4-methylcoumaryl-7-amide) (DEVD-AMC) was from Peptide Institute, Inc. (Osaka, Japan), ATP was from Boehringer Mannheim (Germany), potassium ferricyanide from BDH (Poole, England) and potassium ferrocyanide from Riedel-de Hae$ n A.G. (Hannover, Germany). All other chemicals were from Sigma (St. Louis, MO, U.S.A.).
Cell and extract preparation
Jurkat cells were cultured in RPMI-1640 media with 10 % (v\v) heat-inactivated fetal calf serum and 2 mM glutamine, 100 units\ ml of penicillin and 100 mg\ml streptomycin. Cultures were incubated at 37 mC in humidified air with 5 % CO # , and kept in exponential growth phase. Cells were harvested at 500 g for 5 min, and S-100 extracts were prepared as described by Liu et al. [4] . The buffer included 20 mM Hepes (pH adjusted to 7.5 with KOH), 10 mM KCl, 1.5 mM MgCl # , 1 mM EGTA, 1 mM EDTA, 1 mM dithiothreitol (DTT) and was supplemented with 0.1 mM PMSF, 5 µg\ml pepstatin A, 10 µg\ml leupeptin, 2 µg\ ml aprotinin and 25 µg\ml N-acetyl-leucine-leucine-norleucine. After preparation, extracts were either used immediately, or stored at k80 mC until required. Protein concentrations varied from 2-5 µg\µl of extract, and were determined using the BioRad protein assay with BSA as standard.
Western blots
For protein detection with Western blot, samples were solubilized for 3 min at 100 mC in Laemmli's SDS\PAGE sample buffer. Extracted polypeptides were resolved at 130 V on 12 % (w\v) SDS\PAGE gels and electrophoretically transferred to nitrocellulose (0.2 µm) for 2 h at 100 V. Membranes were blocked overnight in 50 mM Tris (pH 7.5) with 500 mM NaCl, 1 % (w\v) BSA and 5 % (w\v) non-fat dried milk. They were then probed with anti-p17 antibodies (1 : 5000) in blocking solution without milk, followed by 1 h with secondary IgG (1 : 10 000) in an identical solution, and then detected by enhanced chemiluminescence according to the manufacturer's instructions. Membranes were stripped and reprobed with anti-(caspase-7) antibodies (1 : 5000).
Measurement of caspase activity
The measurement of DEVD-AMC cleavage was modified from Nicholson et al. [10] . Extract samples (9 µl) were added to microtitre plates with 50 µl of assay buffer [100 mM Hepes (pH 7.25)\10 % (w\v) sucrose\5 mM DTT\10 −' % NP-40\ 0.1 % (w\v) CHAPS] and 50 µM acetyl-DEVD-AMC. Substrate cleavage to release free aminomethylcoumarin (AMC) (λ excitation 355 nm, λ emission 460 nm) was monitored with time at 37 mC. Units of fluorescence were converted to pmol of AMC using a standard curve generated with free AMC.
Cytochrome c reduction and apocytochrome c
The redox status of cytochrome c was determined by monitoring A &&! on a Shimadzu UV\visible spectrophotometer with the bandwidth setting at 0.5 nm. Apocytochrome c was prepared as described by Fisher et al. [11] .
RESULTS
Post-S-100 cytosolic extracts were prepared from Jurkat Tlymphocytes harvested during the exponential phase of growth [4] . Cytochrome c (400 nM) and dATP (1 mM) were added to this extract, and caspase activity was determined at various intervals. Western-blot analysis showed sequential cleavage of the 32 kDa procaspase-3 to the p20 and p17 fragments ( Figure  1A ). Cleavage of 35 kDa procaspase-7 to the active p20 subunit was also detected ( Figure 1B) . Both processes were time-dependent and involved a lag-phase for procaspase activation. No cleavage could be detected at 15 min, but activation of the caspases was evident at 30 min.
To quantify total caspase activity in the extracts, we assayed the cleavage of the fluorophore AMC from the acetyl-Asp-GluVal-Asp tetrapeptide (DEVD) [10] . Caspase-3 and caspase-7 are two of the major DEVD-cleaving caspases, but other related caspases may also contribute. With this assay, a small amount of activity was detectable at 15 min, which increased rapidly after that time ( Figure 1C) .
Various cytochromes or haem proteins were used to determine if they could substitute for cytochrome c. We tested haemoglobin, cytochrome P-450 (2E1) and cytochrome b5 ; however, all were unsuccessful. In addition, various modifications to cytochrome c, including removal of the haem group resulting in the apoprotein, haem alone (haemin), or microperoxidase-11 (the haem group of cytochrome with amino acids 11-21) could not substitute for the fully functional cytochrome c. Biotinylated cytochrome c from Sigma (St. Louis, MO, U.S.A.) was also ineffective in this respect, emphasizing the stringency for an unmodified protein.
The requirement for a redox-active cytochrome c was investigated. Commercial cytochrome c is present in the oxidized form. Upon addition to cytosolic extracts, it was quickly reduced, as assessed by an increase in A &&! (Figure 2 ). Complete reduction was achieved within 5 min, i.e. approx. 10 min before significant caspase activity was detected. Potassium ferricyanide was used to reoxidize the cytochrome c (Figure 2 ). The absorbance does not return to zero because oxidized cytochrome c also absorbs light at 550 nm. At concentrations exceeding 1 mM, ferricyanide was able to maintain the cytochrome c in its oxidized form (Figure 2) . However, at lower doses, ferricyanide would initially oxidize the resident cytochrome c, but reduction would resume after a short interval (Figure 2 ). Monitoring the loss of absorbance of ferricyanide at 420 nm showed that, as expected, it was rapidly reduced to ferrocyanide (results not shown).
Figure 3 Effect of ferricyanide on cytochrome-c-mediated caspase activation
The ability of ferricyanide-oxidized cytochrome c to activate the caspases was investigated. Ferricyanide at 1 mM blocked caspase activation by over 80 % (Figure 3) , and had no effect on the caspases when added at the end of the incubation period, indicating that it did not interfere with the activity of active caspases (results not shown). However, concentrations below 1 mM, which were not sufficient to maintain cytochrome c in its oxidized form (Figure 2 ), were also effective at blocking caspase activation (Figure 3) . Furthermore, although the addition of potassium ferrocyanide did not alter the redox state of cytochrome c (Figure 2 ), this compound was equally efficient in blocking caspase activation (Figure 3) . Therefore it appears that the iron hexacyanide complexes were having an effect on cytochrome c, independent of their ability to alter its redox state.
We hypothesized that this was due to the polyanionic nature of the hexacyanide complexes. The ability of cytochrome c to perform its normal mitochondrial function depends on physical interactions with the proteins of the electron transport chain that it shuttles electrons between. The evolutionarily highly conserved conformation of cytochrome c includes a cluster of positively charged lysine residues which mediate these interactions [8] . The negatively charged iron hexacyanides could interfere with allosteric interactions mediated through these residues. We investigated the effect of other ions on cytochrome-c-mediated caspase activation. The S-100 extraction buffer already contained 20 mM Hepes, 10 mM KCl and 1.5 mM MgCl # . Addition of increasing concentrations of various salts blocked caspase activation, with the phosphate and sulphate anions being particularly effective (Figure 4a) .
We also investigated whether dATP and ATP would inhibit caspase activation by cytochrome c. Cytochrome c alone can trigger caspase activation, but not as efficiently as when dATP is also present. Addition of either dATP or ATP initially enhanced caspase activation by cytochrome c, but these polyphosphate anions acted as effective inhibitors when their concentrations rose above 2 mM (Figure 4b ).
The polyanionic inhibition by ferricyanide led us to investigate the ability of other compounds to oxidize cytochrome c. However, those that were found to be strong enough to oxidize cytochrome c in the extracts would either cause cytochrome c to be modified or directly oxidize the caspases. Therefore we attempted to prevent the initial reduction of cytochrome c. DTT can effectively reduce cytochrome c (results not shown), and is present at a concentration of 1 mM in the cytoplasmic extract. Removal of DTT from the extract buffer did reduce the rate of cytochrome c reduction, but in its absence, complete reduction still occurred ( Figure 5 ). Reduced glutathione (GSH) will also be present, but this is unable to reduce cytochrome c (results not shown). A range of inhibitors were then used in an attempt to prevent reduction in the DTT-deficient extracts. Superoxide dismutase (500 units\ml of the Cu\Zn-or Mn-or Fe-enzyme) had no effect on either reduction or caspase activation, demonstrating that superoxide plays no role in this system. Other compounds tried were ascorbate oxidase (10 units\ml), the NADPH-diapharose inhibitor dicumarol (10 µM), the flavoprotein inhibitor diphenyleneiodonium (100 µM) and finally, NADP + -2h,3h-dialdehyde (1 mM) and 3-aminopyridine NADP + (1 mM), inhibitors of potential NAD(P)H-utilizing cytochrome reductases that might have been present in the cytosol [12] . None of these effectively prevented cytochrome c reduction (results not shown).
However, one consequence of removing the DTT from the S-100 extraction buffer was that considerably less ferricyanide was required to maintain cytochrome c in its oxidized form ( Figure  5 ). The concentration of ferricyanide required to maintain all of the cytochrome c in an oxidized state during the 45 min of the assay varied between 50 µM and 100 µM, depending on the extract preparation. At 100 µM ferrocyanide, the reduced cytochrome c functioned 50 % as effectively as in untreated extract ( Figure 6 ). In the presence of 100 µM ferricyanide, the completely oxidized cytochrome c functioned with the same efficiency ( Figure  6 ), indicating that cytochrome c reduction is not necessary for caspase activation.
DISCUSSION
Current apoptosis research has been stimulated by the newly discovered export of holocytochrome c from mitochondria to the cytoplasm, along with the realization that cytochrome c is capable of activating the cytoplasmic caspases. Various triggers result in the early detection of cytochrome c in the cytoplasm [5, 6] , but, as yet, we are unable to determine the importance of this process for subsequent apoptotic events. Further progress
